Filter
2675
Filtered Results: 2675
Text search:
Global
Drug
Facility
Featured
Recommendations
263
New Publications
862
Language
Document type
No document type
1655
Guidelines
367
Studies & Reports
360
Manuals
113
Strategic & Response Plan
97
Training Material
31
Fact sheets
28
Situation Updates
13
Resource Platforms
6
Infographics
3
Brochures
1
App
1
Countries / Regions
India
136
Kenya
99
Global
82
Ethiopia
82
Nigeria
75
South Africa
74
Uganda
72
Tanzania
64
Malawi
59
Nepal
58
Liberia
55
Sierra Leone
50
Zambia
50
Ghana
48
Bangladesh
41
Western and Central Europe
40
Myanmar / Burma
39
Rwanda
36
Namibia
33
Africa
31
Eastern Europe
28
Ukraine
27
Zimbabwe
26
Lesotho
25
Asia
25
Cambodia
24
Philippines
23
Latin America and the Carribbean
23
South–East Asia Region
18
Syria
16
Senegal
15
Burkina Faso
15
Mozambique
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
9
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
Tajikistan
6
Benin
6
Haiti
6
West and Central Africa
6
Middle East and North Africa
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Sri Lanka
4
Peru
3
Vietnam
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1208
Clinical Guidelines
239
Public Health
129
Women & Child Health
111
Key Resources
107
Capacity Building
46
Pharmacy & Technologies
36
Toolboxes
TB
340
HIV
296
AMR
157
COVID-19
125
Mental Health
96
Pharmacy
75
NTDs
72
Caregiver
57
Rapid Response
55
NCDs
40
Conflict
35
Ebola & Marburg
33
Planetary Health
29
Refugee
27
Health Financing Toolbox
23
Global Health Education
23
Disability
21
Polio
15
Cholera
11
Natural Hazards
9
Specific Hazards
6
Malaria
6
Zika
3
Social Ethics
2
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro...
A Global Perspective
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr...
Clinical guidelines for the comprehensive care of patients with drug-resistant tuberculosis
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
The report and an accompanying series of studies show the global uptake of the World Health Organization (WHO) Surgical Safety Checklist in its first ten years since its launch and recommend ways the Checklist can be more effectively used to improve surgical safety for millions at risk.
The report ...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
This guideline provides global, evidence-informed recommendations on a number of specific issues related to the management of severe acute malnutrition in infants and children, including in the context of HIV.
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in high morbidity and mortality with ...
